Glycosylation defects in inherited muscle disease

Cellular and Molecular Life Sciences

Volumn 60, Issue 2, 2003, Pages 251-258

  Hewitt, J E ^a   Grewal, P K ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Dystroglycan; Glycosyltransferase; Laminin; Mouse model; Muscular dystrophy; O glycosylation

Indexed keywords

AGRIN; GLYCOSYLTRANSFERASE; LAMININ;

ALLELISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; EYE DISEASE; FKRP GENE; GENE ISOLATION; GENE MUTATION; GLYCOSYLATION; HUMAN; INCLUSION BODY MYOSITIS; INHERITANCE; LIGAND BINDING; LIMB GIRDLE MUSCULAR DYSTROPHY; MOUSE; MULTIGENE FAMILY; MUSCLE DISEASE; MUSCULAR DYSTROPHY; NONAKA MYOPATHY; NONHUMAN; PROTEIN GLYCOSYLATION; REVIEW; SIALIC ACID STORAGE DISEASE;

ANIMALS; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; DYSTROGLYCANS; GLYCOSYLATION; HUMANS; MEMBRANE GLYCOPROTEINS; MUSCULAR DISEASES; MUSCULAR DYSTROPHIES; MUTATION;

ANIMALIA;

EID: 0037301070     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180300020     Document Type: Review

References (75)

1. Cohn R. D. and Campbell K. P. (2000) Molecular basis of muscular dystrophies. Muscle Nerve 23: 1456-1471
2. Blake D. J., Weir A., Newey S. E. and Davies K. E. (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 82: 291-329
3. Durbeej M. and Campbell K. P. (2002) Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr. Op. Gen. Dev. 12: 349-361
4. Winder S. J. (2001) The complexities of dystroglycan. Trends Biochem. Sci. 26: 118-124
5. Henry M. D. and Campbell K. P. (1999) Dystroglycan inside and out. Curr. Opin. Cell Biol. 11: 602-607
6. Campbell K. P. and Allamand V. (2000) Animal models for muscular dystrophy: valuable tools for the development of therapies. Hum. Mol. Genet. 9: 2459-2467
7. Grewal P. K., Holzfeind P. J., Bittner R. E. and Hewitt J. E. (2001) Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse. Nat. Genet. 28: 151-154
8. Brockington M. et al. (2001) Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan. Am. J. Hum. Genet. 69: 1198-1209
9. Brockington M. et al. (2001) Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum. Mol. Genet. 10: 2851-2859
10. Yoshida A. et al. (2001). Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Developmental Cell 1: 717-724
11. Lane P. W., Beamer T. C. and Myers D. D. (1976) Myodystrophy, a new myopathy on chromosome 8 of the mouse. J. Hered. 67: 135-138
12. Grewal P. K. and Hewitt J. E. (2002) Mutation of Large, which encodes a putative glycosyltransferase, in an animal model of muscular dystrophy. Biochim. Biophys. Acta 1573: 216-224
13. Peyrard M. et al. (1999) The human LARGE gene from 22q12.3-q13.1 is a new distinct member of the glycosyltransferase gene family. Proc. Natl. Acad. Sci. USA 96: 598-603
14. Campbell J. A., Davies G. J., Bulone V. and Henrissat B. (1997) A classification of nucleotide-diphospho-sugar glycosyltransferases based on amino acid sequence similarities. Biochem. J. 329: 929-939
15. Heinrichs D. E., Monteiro M. A., Perry M. B. and Whitfield C. (1998) The assembly system for the lipopolysaccharide R2 core-type of Escherichia coli is a hybrid of those found in Escherichia coli K-12 and Salmonella enterica. J. Biol. Chem. 273: 8849-8859
16. Sasaki K. et al. (1997) Expression cloning of cDNA encoding a human β-1,3-N-acetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis. Proc. Natl. Acad. Sci. USA 94: 14294-14299
17. Mathews K. D. et al. (1995) Phenotypic and pathological evaluation of the myd mouse, a candidate model for facioscapulohumeral dystrophy. J. Neuropath. Exp. Neurol. 54: 601-606
18. Ervasti J. M., Ohlendieck K., Kahl S. D., Gaver M. G. and Campbell K. P. (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345: 315-319
19. Herrmann R. et al. (2000) Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Hum. Mol. Genet. 9: 2335-2340
20. Dubowitz V. (1999) 68th ENMC International Workshop: Congenital Muscular Dystrophy. Neuromusc. Dis. 9: 446-454
21. Colognato H. and Yurchenco P. D. (2000) Form and function: the laminin family of heterotrimers. Dev. Dynam. 281: 213-234
22. Helbling-Leclerc A. et al. (1995) Mutations in the laminin α2-chain (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat. Genet. 11: 216-218
23. Muntoni F. and Sewry C. A. (1998) Congenital muscular dystrophy: from rags to riches. Neurology 51: 14-16
24. Pegoraro E. et al. (1998) Laminin alpha 2 muscular dystrophy: genotype/phenotype studies of 22 patients. Neurology 51: 101-110
25. Hayashi Y. K. et al. (1998) Mutations in the integrin alpha7 gene cause congenital myopathy. Nat. Genet. 19: 94-97
26. Vanegas O. C. et al. (2001) Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc. Natl. Acad. Sci. USA 98: 7516-7521
27. Toda T., Kobayashi K., Kondo-Iida E., Sasaki J. and Nakamura Y. (2000) The Fukuyama congenital muscular dystrophy story. Neuromusc. Dis. 10: 153-159
28. Hayashi Y. K. et al. (1993) Abnormal localization of laminin subunits in muscular dystrophies. J. Neurol. Sci. 119: 53-64
29. Ishii H., Hayashi Y. K., Nonaka I. and Arahata K. (1997) Electron microscopic examination of basal lamina in Fukuyama congenital muscular dystrophy. Neuromusc. Dis. 7: 191-197
30. Kobayashi K. et al. (1998) An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394: 388-392
31. Kondo-Lida E. et al. (1999) Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD). Hum. Mol. Genet. 8: 2302-2309
32. Aravind L. and Koonin E. V. (1999) The fukutin protein family - predicted enzymes modifying cell-surface molecules. Current Biol. 9: R836-R837
33. Sasaki J. et al. (2000) Neuronal expression of the fukutin gene. Hum. Mol. Genet. 9: 3083-3090
34. Saito Y., Mizuguchi M., Oka A. and Takashima S. (2000) Fukutin protein is expressed in neurons of the normal developing human brain but is reduced in Fukuyama-type congenital muscular dystrophy brain. Ann. Neurol. 47: 756-764
35. Hayashi Y. K. et al. (2001) Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 57: 115-121
36. Pihkoa H. et al. (1995) Ocular findings in muscle-eye-brain (MEB) disease: a follow-up study. Brain Dev. 17: 57-61
37. Haltia M. et al. (1997) Muscle-eye-brain disease: A neuropathological study. Ann. Neurol. 41: 173-180
38. Auranen M. et al. (2000) Muscle membrane-skeleton protein changes and histopathological characterization of muscle-eye-brain disease. Neuromusc. Dis. 10: 16-23
39. Cormand B. et al. (1999) Assignment of the Muscle-Eye-Brain disease gene to 1p32-p34 by linkage analysis and homozygosity mapping. Am. J. Hum. Genet. 64: 126-135
40. Zhang W. L., Betel C. and Schachter H. (2002) Cloning and expression of a novel UDP-GlcNAc: alpha-D-mannoside beta 1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc:alpha-3-D-mannoside beta 1,2-N-acetylglucosaminyltransferase I. Biochem. J. 361: 153-162
41. Chiba A. K. et al. (1997) Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. J. Biol. Chem. 272: 2156-2162
42. Smalheiser N. R., Haslam S. M., Sutton-Smith M., Morris H. R. and Dell A. (1998) Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain. J. Biol. Chem. 273: 23698-23703
43. Kano H. et al. (2002) Deficiency of α-dystroglycan in Muscle-Eye-Brain disease. Biochem. Biophys. Res. Comm. 291: 1283-1286
44. Cormand B. et al. (2001) Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology 56: 1059-1069
45. Bushby K. (1999) The limb-girdle muscular dystrophies: multiple genes, multiple mechanisms. Hum. Mol. Genet. 8: 1875-1882
46. Driss A. et al. (2000) A new locus for autosomal recessive limb-girdle muscular dystrophy in a large consanguineous Tunisian family maps to chromosome 19q13.3. Neuromusc. Dis. 10: 240-246
47. Eisenberg I. et al. (2001) The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nature Genet. 29: 83-87
48. Kayashima T. et al. (2002) Nonaka myopathy is caused by mutations in the UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase gene (GNE). J. Hum. Genet. 47: 77-79
49. Seppala R., Lehto V. P. and Gahl W. A. (1999) Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme. Am. J. Hum. Genet. 64: 1563-1569
50. Schwarzkopf M. et al. (2002) Sialylation is essential for early development in mice. Proc. Natl. Acad. Sci. USA 99: 5267-5270
51. Griggs R. C. et al. (1995) Inclusion body myositis and myopathies. Ann. Neurol. 38: 705-713
52. Durbeej M. et al. (1995) Non-muscle α-dystroglycan is involved in epithelial development. J. Cell Biol. 130: 79-91
53. Durbeej M., Henry M. D. and Campbell K. P. (1998) Dystroglycan in development and disease. Curr. Opin. Cell Biol. 10: 594-601
54. Hemler M. E. (1999) Dystroglycan versatility. Cell 97: 543-546
55. Matsumura K. et al. (1997) A role of dystroglycan in Schwannoma cell adhesion to laminin. J. Biol. Chem. 272: 13904-13910
56. Williamson R. A. et al. (1997) Dystroglycan is essential for early embryonic development: disruption of Reichart's membrane in Dag 1-null mice. Hum. Mol. Genet. 6: 831-841
57. Ervasti J. M. and Campbell K. P. (1991) Membrane organisation of the dystrophin-glycoprotein complex. Cell 66: 1121-1131
58. Ervasti J. M., Burwell A. L. and Geissler A. L. (1997) Tissue-specific heterogeneity in α-dystroglycan sialoglycosylation. J. Biol. Chem. 272: 22315-22321
59. Gee S. H. et al. (1993) Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J. Biol. Chem. 268: 14972-14980
60. Yamada H., Shimizu T., Tanaka T., Campbell K. P. and Matsumura K. (1994) Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett. 352: 49-53
61. Brancaccio A., Schulthess T., Gesemann M. and Engel J. (1995) Electron microscopic evidence for a mucin-like region in chick muscle α-dystroglycan. FEBS Lett. 368: 139-142
62. McDearmon E. L., Combs A. C. and Ervasti J. M. (2001) Differential Vicia villosa agglutinin reactivity identifies three distinct dystroglycan complexes in skeletal muscle. J. Biol. Chem. 276: 35078-35086
63. 2J mice. Hum. Mol. Genet. 4: 1055-1061
64. Xu H., Wu X.-R., Wewer U. M. and Engvall E. (1994) Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene. Nature Genet. 8: 297-301
65. Yamada H. et al. (1996) Characterisation of dystroglycanlaminin interaction in peripheral nerve. J. Neurochem. 66: 1518-1524
66. Ervasti J. M. and Campbell K. P. (1991) Membrane organization of the dystrophin-glycoprotein complex. Cell 66: 1121-1131
67. Sasaki T. et al. (1998) Detection of O-mannosyl glycans in rabbit skeletal muscle α-dystroglycan. Biochim. Biophys. Acta 1425: 599-606
68. Pall E. A., Bolton K. M. and Ervasti J. M. (1996) Differential heparin inhibition of skeletal muscle α-dystroglycan binding to laminins. J. Biol. Chem. 271: 3817-3821
69. Talts J., Andac Z., Göhring W., Brancaccio A. and Timpl R. (1999) Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins. EMBO J. 18: 863-870
70. Timpl R. et al. (2000) Structure and function of laminin LG modules. Matrix Biology 19: 309-317
71. Sugita S. et al. (2001) A stoichiometric complex of neurexins and dystroglycan in brain. J. Cell Biol. 154: 435-445
72. Denzer A. J. et al. (1998) Electron microscopic structure of agrin and mapping of its binding site in laminin-1. EMBO J. 17: 335-343
73. Ruegg M. A. and Bixby J. L. (1998) Agrin orchestrates synaptic differentiation at the vertebrate neuromuscular junction. Trends Neurosci. 21: 22-27
74. Michele D. E. et al. (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418: 417-422
75. Moore S. A. et al. (2002) Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418: 422-425